Enovix Corporation
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $31.8M | $23.1M | $7.6M | $0 | $0 |
| Cost of Revenue | $25.7M | $25.1M | $63.1M | $2.0M | $3.4M |
| Gross Profit | $6.1M | $-2.0M | $-55.4M | $-2.0M | $-3.4M |
| Gross Margin | 19.2% | -8.9% | -725.0% | — | — |
| Operating Expenses | |||||
| Research & Development | $110.3M | $124.5M | $88.4M | $37.9M | $14.4M |
| SG&A Expense | $73.0M | $74.3M | $79.0M | $29.7M | $5.7M |
| Operating Income | $-177.3M | $-242.7M | $-230.3M | $-69.5M | $-23.5M |
| Operating Margin | -557.0% | -1,051.7% | -3,012.2% | — | — |
| Interest Expense | $12.4M | $6.8M | $4.5M | $187.0K | — |
| Pretax Income | $-157.9M | $-223.9M | $-214.8M | $-125.9M | $-39.7M |
| Income Tax Expense | $-1.3M | $-1.4M | $-633.0K | $0 | $0 |
| Net Income | $-156.7M | $-222.2M | $-214.1M | $-125.9M | $-39.7M |
| Net Margin | -492.6% | -963.2% | -2,800.5% | — | — |
| EPS (Basic) | $-0.75 | $-1.19 | $-1.27 | $-1.07 | $-0.49 |
| EPS (Diluted) | $-0.75 | $-1.19 | $-1.30 | $-1.07 | $-0.49 |
| Shares Outstanding (Basic) | 207.6M | 186.0M | 169.1M | 117.2M | 80.4M |
| Shares Outstanding (Diluted) | 207.6M | 186.0M | 169.6M | 117.2M | 80.4M |
| Dividends Per Share | — | — | — | — | — |